US2016263154A1PendingUtilityA1
Compositions and methods for altering human cutaneous microbiome to increase growth of staphylococcus epidermidis and reduce staphylococcus aureus proliferation
Assignee: UNIV NEW YORK STATE RES FOUNDPriority: Sep 29, 2014Filed: May 19, 2016Published: Sep 15, 2016
Est. expirySep 29, 2034(~8.2 yrs left)· nominal 20-yr term from priority
A61K 33/30A61K 9/0014A61K 31/198A61K 47/02A61Q 17/005A61K 8/44A61K 9/0019A61K 8/27A61K 9/08A61Q 15/00A61K 47/183A61K 2800/592
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An antibacterial composition comprising arginine bicarbonate, zinc carbonate, preferably arginine bicarbonate and zinc carbonate (ABZC), in combination, plus one or more physiologically acceptable excipients, administered for the modification of cutaneous microfloras, generally to inhibit the growth of pathogenic Staphylococcus aureus bacteria by promoting the growth of non-pathogenic Staphylococcus epidermidis bacteria.
Claims
exact text as granted — not AI-modified1 . An antibacterial composition, comprising:
a. arginine, or a salt thereof; b. a zinc salt; c. optionally, a buffer sufficient to maintain the pH of said composition at 6.0 or greater upon topical application; and d. a physiologically-acceptable carrier suitable for topical application, said composition being capable of inhibiting the growth and/or metabolism of Staphylococcus aureus to a greater extent than the growth and/or metabolism of Staphylococcus epidermidis.
2 . The composition of claim 1 , further comprising phenylalanine.
3 . The composition of claim 1 , said composition being capable of inhibiting the growth and/or metabolism of malodor-generating microbiota present in the cutaneous regions of a subpart of the human body.
4 . The composition of claim 3 , wherein said cutaneous regions comprise the axilla, foot-webs and nasal atrium.
5 . The composition of claim 1 , wherein said zinc salt is selected from zinc carbonate and zinc bicarbonate.
6 . The composition of claim 1 , wherein said arginine, or a salt thereof is selected from arginine, arginine carbonate and arginine bicarbonate.
7 . The composition of claim 1 , wherein said zinc salt is zinc carbonate and said arginine salt is arginine bicarbonate.
8 . The composition of claim 1 , wherein said composition is provided as a topical formulation selected from the group selected from soap, spray, drop, aerosol, powder, roll-on, lotion, cream, stick, solution, sachet, colloidal suspension, film, patch and ointment.
9 . (canceled)Join the waitlist — get patent alerts
Track US2016263154A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.